Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Double-Blind, Parallel-Group, Confirmatory Clinical Trial to Verify the Efficacy and Safety of the Cognitive Improvement Effect on Executive Function in Medication-Treated Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease Using the Neuclare Physical Device for Medical Use
Conditions
Interventions
Participants receive Neuclare Device while continuing their cognitive medication
Participants receive Sham Neuclare Device while continuing their cognitive medication
Locations
3
South Korea
Hallym University Dongtan Sacred Heart Hospital
Hwaseong-si, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Ewha Womans University Mokdong Hospital
Seoul, South Korea
Start Date
November 20, 2025
Primary Completion Date
June 1, 2026
Completion Date
July 1, 2026
Last Updated
December 10, 2025
NCT07101380
NCT06121544
NCT07220668
NCT04123314
NCT06780917
NCT07083154
Lead Sponsor
Deepsonbio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions